Pharmacokinetics of lorazepam in critically ill neonates with seizures.

[1]  J. Kanto,et al.  Cerebrospinal fluid concentrations and serum protein binding of lorazepam and its conjugate. , 2009, Acta pharmacologica et toxicologica.

[2]  W. Evans,et al.  Lorazepam pharmacodynamics and pharmacokinetics in children. , 1989, The Journal of pediatrics.

[3]  S. R. Snodgrass,et al.  Lorazepam in childhood status epilepticus and serial seizures , 1987, Neurology.

[4]  A. Deshmukh,et al.  Lorazepam in the treatment of refractory neonatal seizures. A pilot study. , 1986, American journal of diseases of children.

[5]  D. J. Lacey,et al.  Lorazepam therapy of status epilepticus in children and adolescents. , 1986, The Journal of pediatrics.

[6]  R. Ramsay,et al.  Double-blind study of lorazepam and diazepam in status epilepticus. , 1983, JAMA.

[7]  B. Mulley,et al.  Plasma concentrations and clinical effects of lorazepam after oral administration. , 1981, British journal of anaesthesia.

[8]  P. Morselli,et al.  Clinical Pharmacokinetics in Newborns and Infants , 1980 .

[9]  D. Greenblatt,et al.  Entry of lorazepam into cerebrospinal fluid [letter] , 1980 .

[10]  B. Wilder,et al.  Brain uptake of phenytoin, phenobarbital, and diazepam. , 1979, Archives of Neurology.

[11]  R. Homan,et al.  Lorazepam in status epilepticus , 1979, Annals of neurology.

[12]  H. W. Elliott.  Metabolism of lorazepam. , 1976, British journal of anaesthesia.

[13]  D. Greenblatt,et al.  Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans , 1979 .